284 related articles for article (PubMed ID: 24166736)
1. Lipoxin A₄ modulates adaptive immunity by decreasing memory B-cell responses via an ALX/FPR2-dependent mechanism.
Ramon S; Bancos S; Serhan CN; Phipps RP
Eur J Immunol; 2014 Feb; 44(2):357-69. PubMed ID: 24166736
[TBL] [Abstract][Full Text] [Related]
2. Evidence for an anti-inflammatory loop centered on polymorphonuclear leukocyte formyl peptide receptor 2/lipoxin A4 receptor and operative in the inflamed microvasculature.
Brancaleone V; Dalli J; Bena S; Flower RJ; Cirino G; Perretti M
J Immunol; 2011 Apr; 186(8):4905-14. PubMed ID: 21398608
[TBL] [Abstract][Full Text] [Related]
3. Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A₄.
Hanson J; Ferreirós N; Pirotte B; Geisslinger G; Offermanns S
Biochem Pharmacol; 2013 Jun; 85(12):1795-802. PubMed ID: 23643932
[TBL] [Abstract][Full Text] [Related]
4. FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis.
Maderna P; Cottell DC; Toivonen T; Dufton N; Dalli J; Perretti M; Godson C
FASEB J; 2010 Nov; 24(11):4240-9. PubMed ID: 20570963
[TBL] [Abstract][Full Text] [Related]
5. Lack of activity of 15-epi-lipoxin A₄ on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function.
Planagumà A; Domenech T; Jover I; Ramos I; Sentellas S; Malhotra R; Miralpeix M
Clin Exp Immunol; 2013 Aug; 173(2):298-309. PubMed ID: 23607720
[TBL] [Abstract][Full Text] [Related]
6. Lipoxin A4 activates ALX/FPR2 to attenuate inflammation in Aspergillus fumigatus keratitis.
Zhu X; Peng X; Lin J; Zhang Y; He H; Zhao G
Int Immunopharmacol; 2021 Jul; 96():107785. PubMed ID: 34162149
[TBL] [Abstract][Full Text] [Related]
7. The G-Protein-Coupled Receptor ALX/Fpr2 Regulates Adaptive Immune Responses in Mouse Submandibular Glands.
Wang CS; Baker OJ
Am J Pathol; 2018 Jul; 188(7):1555-1562. PubMed ID: 29684359
[TBL] [Abstract][Full Text] [Related]
8. Lipoxin A4 inhibits immune cell binding to salivary epithelium and vascular endothelium.
Chinthamani S; Odusanwo O; Mondal N; Nelson J; Neelamegham S; Baker OJ
Am J Physiol Cell Physiol; 2012 Apr; 302(7):C968-78. PubMed ID: 22205391
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene B4/antimicrobial peptide LL-37 proinflammatory circuits are mediated by BLT1 and FPR2/ALX and are counterregulated by lipoxin A4 and resolvin E1.
Wan M; Godson C; Guiry PJ; Agerberth B; Haeggström JZ
FASEB J; 2011 May; 25(5):1697-705. PubMed ID: 21307335
[TBL] [Abstract][Full Text] [Related]
10. Lack of resolution sensor drives age-related cardiometabolic and cardiorenal defects and impedes inflammation-resolution in heart failure.
Tourki B; Kain V; Pullen AB; Norris PC; Patel N; Arora P; Leroy X; Serhan CN; Halade GV
Mol Metab; 2020 Jan; 31():138-149. PubMed ID: 31918915
[TBL] [Abstract][Full Text] [Related]
11. Lipoxin-mediated signaling: ALX/FPR2 interaction and beyond.
Sánchez-García S; Jaén RI; Fernández-Velasco M; Delgado C; Boscá L; Prieto P
Pharmacol Res; 2023 Nov; 197():106982. PubMed ID: 37925045
[TBL] [Abstract][Full Text] [Related]
12. Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.
Colby JK; Gott KM; Wilder JA; Levy BD
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):25-33. PubMed ID: 26039320
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-181b regulates ALX/FPR2 receptor expression and proresolution signaling in human macrophages.
Pierdomenico AM; Recchiuti A; Simiele F; Codagnone M; Mari VC; Davì G; Romano M
J Biol Chem; 2015 Feb; 290(6):3592-600. PubMed ID: 25505240
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory circuitry: lipoxin, aspirin-triggered lipoxins and their receptor ALX.
Chiang N; Arita M; Serhan CN
Prostaglandins Leukot Essent Fatty Acids; 2005; 73(3-4):163-77. PubMed ID: 16125378
[TBL] [Abstract][Full Text] [Related]
15. Lipoxin A
Gaudin A; Tolar M; Peters OA
Sci Rep; 2018 Jun; 8(1):8921. PubMed ID: 29892010
[TBL] [Abstract][Full Text] [Related]
16. The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.
Chiang N; Serhan CN; Dahlén SE; Drazen JM; Hay DW; Rovati GE; Shimizu T; Yokomizo T; Brink C
Pharmacol Rev; 2006 Sep; 58(3):463-87. PubMed ID: 16968948
[TBL] [Abstract][Full Text] [Related]
17. Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor.
Dalli J; Consalvo AP; Ray V; Di Filippo C; D'Amico M; Mehta N; Perretti M
J Immunol; 2013 Jun; 190(12):6478-87. PubMed ID: 23686496
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic regulation of the formyl peptide receptor 2 gene.
Simiele F; Recchiuti A; Patruno S; Plebani R; Pierdomenico AM; Codagnone M; Romano M
Biochim Biophys Acta; 2016 Oct; 1859(10):1252-8. PubMed ID: 27424221
[TBL] [Abstract][Full Text] [Related]
19. A novel rat lipoxin A4 receptor that is conserved in structure and function.
Chiang N; Takano T; Arita M; Watanabe S; Serhan CN
Br J Pharmacol; 2003 May; 139(1):89-98. PubMed ID: 12746227
[TBL] [Abstract][Full Text] [Related]
20. ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland.
Wang CS; Wee Y; Yang CH; Melvin JE; Baker OJ
Sci Rep; 2016 Apr; 6():24244. PubMed ID: 27064029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]